Search for: "NOVARTIS AG" Results 161 - 180 of 440
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Nov 2007, 3:06 pm
The October 2007 FDA staff report was prepared in advance of a meeting of an advisory panel of pediatricians later this week being convened to consider the safety of Serevent and Advair (made by GlaxoSmithKline PLC), both of which contain the active ingredient salmeterol, as well as another asthma drug, Foradil (made by Novartis AG and marketed in the U.S. by Schering-Plough Corp.), which contains the active ingredient formoterol. [read post]
27 Jun 2022, 11:00 pm by Matthieu Dhenne (Ipsilon)
The European patent application EP 2 959 894, that covers the said speciality, was invoked by its proprietor (NOVARTIS AG) as the basis for a request for a preliminary injunction, immediately after the EPO Board of Appeal had ordered the Examining Division to grant the patent on the basis of one of the claims submitted by the applicant. [read post]
4 Dec 2015, 2:55 am
Novartis AG & Novartis GmbH regarding the validity and (in)direct infringement of EP 0296 689, Novartis’ Swiss type 2nd medical use patent covering the use of zoledronate in the preparation of a medicament for the treatment of osteoporosis. [read post]
21 Oct 2007, 12:55 pm
One such drug is Zelnorm ® , a drug used in the treatment of Irritable Bowel Syndrom ("IBS") and chronic constipation in individuals under 65 years of age. [read post]
20 Dec 2021, 12:45 pm by Tom Lamb
We will continue to watch for Beovu safety developments which are presented in medical journals or addressed in medical news reports, as well as an anticipated Beovu label change previewed by Novartis back in May 2021 (see: "Beovu Vision Loss Side Effects Continue to Plague Novartis, Ending 3 Key Clinical Trials in May 2021"). [read post]
18 Feb 2013, 5:48 am
You can also get in touch with Novartis for information about a refund. [read post]
10 Mar 2021, 12:13 pm by Tom Lamb
The basic liability allegations in those Beovu lawsuits, as well as other Beovu cases concerning Beovu eye problems, are: Novartis misrepresented that Beovu was a safe treatment for age-related macular degeneration; and, Novartis failed to warn about Beovu eye injection reactions causing vision loss and blindness. [read post]
10 Jul 2020, 7:09 am by MaxVal
Apple’s new patent on spatial audio proves it is serious about the rumored “Apple Glasses” and AR/VR In this week’s featured patents, we cover the latest patent applications from IBM, Intel, Apple, Boston Scientific, Medtronic, Merck, and Novartis. [read post]
18 Jul 2022, 2:11 pm by Jeff R. Vaisa
Novartis Pharma AG According to a recent case in the U.S. [read post]
14 May 2013, 3:10 pm by Angel Reyes
  Major brand names of these medications include Novartis, Pfizer, Triaminic, Dimetapp and Robitussin. [read post]
5 Oct 2016, 6:59 pm by Rik Lambers
In the Novartis/Sun case the Swiss type claim has now passed the AG and entered the Supreme Court’s chambers for consideration; the MSD / Teva case is to follow. [read post]
29 Sep 2020, 3:40 pm by Tom Lamb
[Beovu (brolucizumab)] is not the only drug that can be used for the treatment of [exudative age-related macular degeneration (eAMD)]. [read post]
25 Jun 2018, 3:49 am by Boris Malakhov
Starting from 2009, when the Supreme Commercial Court restrained a generic drug for the first time (Novartis AG vs. [read post]
20 Jul 2009, 2:00 pm
To reassess the CV safety of tegaserod, teagaserod-treated patients (pts) in the Intermountain Healthcare database were identified (n = 2603), matched 1:6 with untreated (n = 15,618) patients by age, sex, and date of tegaserod initiation, and followed for an average of 2.5 years.... [read post]